Harderwijk, Netherlands

Jeroen Lammerts Van Bueren

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeroen Lammerts Van Bueren: Innovator in Cancer Treatment

Introduction

Jeroen Lammerts Van Bueren is a notable inventor based in Harderwijk, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic methods.

Latest Patents

Jeroen holds a patent for "Methods and antibodies for treating cancer." This invention relates to novel methods for the treatment of tumors, which involve the administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention focuses on a method for inducing complement-mediated cell killing in the treatment of a tumor. This method comprises the combined administration, to a human being in need thereof, of a first antibody and a second antibody.

Career Highlights

Jeroen is currently associated with Genmab A/S, a leading biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer. His work at Genmab has been pivotal in advancing cancer therapies and improving patient outcomes.

Collaborations

Throughout his career, Jeroen has collaborated with esteemed colleagues, including Jan Van De Winkel and Paul Parren. These collaborations have fostered innovation and have been instrumental in the development of groundbreaking cancer treatments.

Conclusion

Jeroen Lammerts Van Bueren is a distinguished inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. His contributions continue to pave the way for advancements in therapeutic strategies against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…